Other Information
−Removed: License Agreement, dated April 14, 2021, between the Company and OyaGen, Inc.
−Removed: Certification of Chief Executive
−Removed: Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
−Removed: Certification of Chief Financial Officer pursuant to
−Removed: Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
−Removed: Certifications of Chief Executive Officer and Chief
−Removed: Financial Officer pursuant to 18 U.S.C.
+Added: Purchase and Sale Agreement, dated July 26, 2021, between the Company and Southern Research
+Added: Certification of Chief Executive Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
+Added: Certification of Chief Financial Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
+Added: Certifications of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C.
Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
2 unchanged sentences
XBRL Taxonomy Calculation Linkbase Document
−Removed: XBRL Taxonomy Extension Definition Linkbase Document
XBRL Taxonomy Labels Linkbase Document
XBRL Taxonomy Presentation Linkbase Document
−Removed: Certain portions of this exhibit, that are
−Removed: not material and would likely cause competitive harm to the registrant if publicly disclosed, have been redacted pursuant to Item 601(b)(10)
−Removed: of Regulation S-K.
−Removed: to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
−Removed: the undersigned thereunto duly authorized.
+Added: Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)
+Added: Pursuant to the requirements
+Added: of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto
+Added: duly authorized.
TONIX PHARMACEUTICALS HOLDING CORP.
−Removed: SETH LEDERMAN
+Added: August 9, 2021
+Added: /s/ SETH LEDERMAN
Seth Lederman
−Removed: Chief Executive Officer (Principal Executive Officer)
−Removed: BRADLEY SAENGER
+Added: Chief Executive Officer (Principal Executive
+Added: August 9, 2021
+Added: /s/ BRADLEY SAENGER
Bradley Saenger
−Removed: Financial Officer (Principal Financial Officer
−Removed: Principal Accounting Officer)
+Added: Chief Financial Officer (Principal Financial Officer
+Added: and Principal Accounting Officer)
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.